LANCHBURY JERRY S

CIK 00012190361 companySALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001219036

Recent Transactions

50 trades

Tax Payment
MYRIAD GENETICS INC$MYGN
Common Stock
2021-10-09$30.88/sh−4,341→ 270,794 total
Tax Payment
MYRIAD GENETICS INC$MYGN
Common Stock
2021-10-09$30.88/sh−6,470→ 264,324 total
Tax Payment
MYRIAD GENETICS INC$MYGN
Common Stock
2021-09-26$33.31/sh−3,633→ 275,135 total
Tax Payment
MYRIAD GENETICS INC$MYGN
Common Stock
2021-09-25$33.31/sh−9,747→ 278,768 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-09-23$35.06/sh−200→ 288,515 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2021-09-21+58,398→ 288,715 total
Tax Payment
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-25$34.81/sh−2,233→ 230,317 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-08-24−30,000→ 0 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-24$35.57/sh−30,000→ 232,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-24$27.07/sh+30,000→ 262,550 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-23$35.57/sh−10,000→ 232,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-08-23−10,000→ 70,000 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-08-23−40,000→ 30,000 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-23$35.07/sh−40,000→ 232,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-23$27.07/sh+10,000→ 242,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-23$27.07/sh+40,000→ 272,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-08-05−28,225→ 80,000 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-05$27.07/sh+28,225→ 260,775 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-05$35.57/sh−28,225→ 232,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-04$27.07/sh+11,775→ 244,325 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-08-04−38,225→ 120,000 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-08-04−11,775→ 108,225 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-04$35.57/sh−11,775→ 232,550 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-04$35.24/sh−38,225→ 232,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-04$27.07/sh+38,225→ 270,775 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-08-03−16,225→ 0 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-03$27.07/sh+1,775→ 234,325 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-03$34.00/sh−27,830→ 232,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-08-03−1,775→ 158,225 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Incentive Stock Option (right to buy)
2021-08-03−4,170→ 0 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-03$35.07/sh−1,775→ 232,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-08-03−27,830→ 0 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-03$23.98/sh+4,170→ 236,720 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-03$34.00/sh−4,170→ 232,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-03$26.49/sh+16,225→ 248,775 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-03$33.99/sh−16,225→ 232,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-08-03$23.98/sh+27,830→ 260,380 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-07-13$26.49/sh+40,000→ 272,550 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-07-13$33.69/sh−3,295→ 232,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-07-13−40,000→ 16,225 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-07-13−3,295→ 56,225 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-07-13$33.74/sh−40,000→ 232,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-07-13$26.49/sh+3,295→ 235,845 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-07-12$33.55/sh−36,705→ 232,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-07-12$26.49/sh+13,295→ 245,845 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Common Stock
2021-07-12$26.49/sh+36,705→ 269,255 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-07-12$33.55/sh−13,295→ 232,550 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-07-12−13,295→ 59,520 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-07-12−36,705→ 72,815 total
Exercise/Conversion
MYRIAD GENETICS INC$MYGN
Non-Qualified Stock Option (right to buy)
2021-07-09−5,603→ 109,520 total

Companies

MYRIAD GENETICS INC
Executive V.P. - Research
$MYGN

Recent Filings

Address

320 WAKARA WAY

SALT LAKE CITY, UT, 84108

View on SEC.gov